MM
Metzger Michael A
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Metzger Michael A, Chairman & CEO. Insider active across 3 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 25 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €1.3m. History available since 13 September 2021. The latest transaction was filed on 8 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Metzger Michael A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
32,375 shares@ US$6.380.0095% mcap10.5% of flowCommon StockSEC:0001193125-26-299803:0
32,375 shares@ US$24.24020.036% mcap39.7% of flowCommon StockSEC:0001193125-26-299803:1
17,159 shares@ US$21.02811.0% of flowCommon StockSEC:0001193125-26-043814:0
73,000 shares0Common StockSEC:0001193125-26-041500:0
157,307 shares@ US$10.9058.9% of flowCommon StockSEC:0000950170-25-113659:0
7,534 shares@ US$9.2855.9% of flowCommon StockSEC:0000950170-25-096947:0
6,074 shares@ US$7.204.2% of flowCommon StockSEC:0000950170-25-039787:0
7,814 shares@ US$7.205.6% of flowCommon StockSEC:0000950170-25-034634:0
13,288 shares@ US$15.50420.9% of flowCommon StockSEC:0000950170-25-019000:0
60,500 shares0Common StockSEC:0000950170-25-016384:0
107,250 shares0Common StockSEC:0001562180-24-001223:0
5,959 shares@ US$6.383.7% of flowCommon StockSEC:0001562180-23-001118:0
28,500 shares@ US$0.841115.3% of flowcommon stockSEC:0000891293-22-000055:0
16,231 shares@ US$8.7715.2% of flowCommon StockSEC:0001562180-22-007124:0
29,606 shares@ US$8.7727.6% of flowCommon StockSEC:0001562180-22-007012:0
19,764 shares@ US$6.3812.9% of flowCommon StockSEC:0001562180-22-005761:0
9,000 shares@ US$6.5036.8% of flowcommon stockSEC:0000891293-22-000036:0
15,009 shares@ US$6.389.8% of flowCommon StockSEC:0001562180-22-005637:0
91,500 shares@ US$0.841147.9% of flowcommon stockSEC:0000891293-22-000035:0
22,715 shares@ US$6.387.4% of flowCommon StockSEC:0001562180-21-007809:0
2,045 shares@ US$7.200.8% of flowCommon StockSEC:0001562180-21-007710:0
44,704 shares@ US$7.2016.0% of flowCommon StockSEC:0001562180-21-006652:0
24,437 shares@ US$7.208.7% of flowCommon StockSEC:0001562180-21-006136:0
31,455 shares@ US$7.2011.1% of flowCommon StockSEC:0001562180-21-006060:0
16,651 shares@ US$7.205.9% of flowCommon StockSEC:0001562180-21-005948:0
About Metzger Michael A
Metzger Michael A is Président-Directeur Général. He has 25 filings in total, and across the 25 sampled recent filings the transactions cover the period from 2021-09-15 to 2026-07-09, with 0 in buys and 1310717 in sales. The filings concern Syndax Pharmaceuticals Inc and CTI Biopharma CORP, and the most common transaction nature is option exercise.